Genetesis recently announced that it has raised $17.5 million in a Series C round to further support its next-generation biomagnetic imaging technology. Mithril Capital led the new round. There was also participation from Cercano Management and existing investors, including JobsOhio Growth Capital, Ohio Innovation Fund and CincyTech. This investment brings the Mason, Ohio–based company’s total funding […]
Genetesis
Genetesis wins FDA breakthrough nod for imaging tech
Cardiac imaging technology developer Genetesis announced today that its flagship product received FDA breakthrough device designation. Mason, Ohio-based Genetesis’ CardioFlux magnetocardiograph (MCG) uses highly sensitive room temperature magnetometers to deliver non-invasive measurements of the heart’s naturally generated magnetic fields, according to a news release. The FDA granted breakthrough device designation for CardioFlux in the diagnosis of […]
Genetesis completes $9.2m Series B
Cardiac imaging technology developer Genetesis announced today that it completed a Series B financing round worth $9.2 million. Significant investments from TDK Ventures and an undisclosed Fortune 500 company helped to complete the funding, according to a news release. Returning investors CincyTech, Ohio Innovation Fund and Mark Cuban also contributed. Mason, Ohio-based Genetesis develops the […]
Innoblative taps ex-Lumicell chief Londy for CEO | Personnel Moves, Sept. 13, 2019
Innoblative Designs last week named former Lumicell chief executive Kelly Londy as its new CEO. Apart from her two-year stint at the Lumicell helm, Londy was COO at Accuray (NSDQ:ARAY) and worked at GE Healthcare and Philips Healthcare. “Innoblative’s Sira RF ablation device offers unique capabilities that address shortcomings in the current advanced energy surgical market,” […]
FDA clears Genetesis’ CardioFlux biomagnetic cardiac imager
Genetesis said last Friday it won FDA 510(k) clearance for its CardioFlux biomagnetic cardiac imaging platform. The newly cleared platform combines the CardioFlux magnetocardiograph with an integrated Faraday Analytical Cloud, the Mason, Ohio-based company said. Genetesis said that the CardioFlux uses a next-gen version of magnetocardiography that eliminates the need for liquid helium cooling, which […]
Genetesis lands $1m seed round for CardioFlux heart imaging device
Genetesis said today that it raised a $1.2 million seed round for its CardioFlux heart imaging device. Cincinatti-based Genetesis said the round was led by CincyTech and Mark Cuban’s Radical Investments and included Loud Capital, Danmar Capital, Wilson Sonsini Investment Company, Genetesis management and private angels. The CardioFlux device is designed to create a 3D map to characterize the […]
